Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Lawrence Remmel Insider Profile
4 Followers
Lawrence Remmel, Director at Atossa Therapeutics, holds 9.40K shares in Atossa Therapeutics (Ticker: ATOS). Most recently, Lawrence Remmel Bought $2,500 shares of Atossa Therapeutics on Apr 18, 2017 for an estimated value of 1.57K.
Profitable Transactions
0 out of 5 Profitable Transactions
Average Return
-58.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Lawrence Remmel's holdings
Insider Roles
Director
Roles that Lawrence Remmel holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Apr 18, 2017 - Apr 18, 2018
Return:-43.10%
The most profitable trade made by Lawrence Remmel
Lawrence Remmel's Trading History
List of latest transactions for each holding click on a transaction to see Lawrence Remmel's performance on stock
You May Also Like
Lawrence Remmel insider profile FAQ
What is the percentage of profitable transactions made by Lawrence Remmel?
The percentage of profitable transactions made by Lawrence Remmel is 0%.
What is the average return per transaction made by Lawrence Remmel?
The average return per transaction made by Lawrence Remmel is -58.40%.
What stocks does Lawrence Remmel hold?
Lawrence Remmel holds: ATOS stocks.
What was Lawrence Remmel’s latest transaction?
Lawrence Remmel latest transaction was an Informative Buy of $1.57K.
What was Lawrence Remmel's most profitable transaction?
Lawrence Remmel’s most profitable transaction was an Informative Buy of ATOS stock on April 18, 2017. The return on the trade was -43.10%.
What is Lawrence Remmel's role in Atossa Therapeutics?
Lawrence Remmel's role in Atossa Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.